Skip to content

A research to study the efficacy of pain reprocessing therapy, an intervention for pain for patients of Fibromyalgia in comparison with the Jacobsons Progressive Muscle Relaxation.

Pain reprocessing therapy in patients with Fibromyalgia- a randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059606
Enrollment
20
Registered
2023-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M797- Fibromyalgia

Interventions

Intervention1: PRT: 8 sessions 2 sessions per week Control Intervention1: JPMR: Pain reprocessing therapy 8 sessions - 2 sessions/week JPMR for 8 sessions- 2 sessions /week

Sponsors

Amrita Institute Of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Males and females of age ranging from 20 to 55 years. Individuals who are diagnosed with Fibromyalgia. Individuals with minimum 10 years of education

Exclusion criteria

Exclusion criteria: No reported history of traumatic brain injury. No reported physical disorders where pain is primary complaint. No reported history of chronic neurological condition where pain is the primary symptom.

Design outcomes

Primary

MeasureTime frame
A comparison of Pre- intervention and post-intervention scores on Bodily and Emotional Perception of Pain questionnaire (BEEP) in both groups will be considered as primary outcome. Timepoint: Time points: Pre intervention Baseline assessments Post intervention: 5 weeks Follow up assessmnent: 9 weeks

Secondary

MeasureTime frame
To assess the Bodily and Emotional Perception of Pain To assess the symptoms severity before and after PRT by using behavioural evaluation measures. To assess the effect of PRT at one month follow up. Timepoint: 1 month post intervention

Countries

India

Contacts

Public ContactDr Dhanya Chandran

Amrita Institute of Medical Sciences

dhanyachandran@aims.amrita.edu9632924978

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026